MedTrace Logo

Hormones and Decision Making

NCT04865562 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-04-29

No results posted yet for this study

Summary

An investigation of the neuropsychological processes underlying ethical decision making.

Conditions

  • Dyssocial Behavior

Interventions

DRUG

testosterone propionate

1mg/0.1mL solution, to be administered intranasally

DRUG

0.5% cholorbutanol, saline

125 mg 0.5% cholorbutanol, 50mg saline

Sponsors & Collaborators

  • University of Texas at Austin

    lead OTHER

Principal Investigators

  • Robert A Josephs, PhD · University of Texas at Austin

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-01
Primary Completion
2016-05-01
Completion
2016-09-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04865562 on ClinicalTrials.gov